Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Collegium Pharmaceutical (COLL) Leases (2019 - 2026)

Collegium Pharmaceutical has reported Leases over the past 7 years, most recently at $4.2 million for Q4 2025.

  • For Q4 2025, Leases fell 28.08% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, down 28.08%, while the annual FY2025 figure was $4.2 million, 28.08% down from the prior year.
  • Leases for Q4 2025 was $4.2 million at Collegium Pharmaceutical, down from $4.4 million in the prior quarter.
  • Over five years, Leases peaked at $8.2 million in Q1 2021 and troughed at $4.2 million in Q4 2025.
  • A 5-year average of $6.4 million and a median of $6.3 million in 2023 define the central range for Leases.
  • Biggest five-year swings in Leases: dropped 1.19% in 2024 and later dropped 28.16% in 2025.
  • Year by year, Leases stood at $7.6 million in 2021, then fell by 10.24% to $6.9 million in 2022, then dropped by 12.13% to $6.0 million in 2023, then dropped by 3.43% to $5.8 million in 2024, then dropped by 28.08% to $4.2 million in 2025.
  • Business Quant data shows Leases for COLL at $4.2 million in Q4 2025, $4.4 million in Q3 2025, and $5.3 million in Q2 2025.